Immunome Inc
NASDAQ:IMNM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cubic Sensor and Instrument Co Ltd
SSE:688665
|
CN |
|
Kura Sushi Inc
TSE:2695
|
JP |
|
C
|
CaoCao Inc
HKEX:2643
|
CN |
|
MANAC Chemical Partners Co Ltd
TSE:4360
|
JP |
|
L
|
Landsea Green Properties Co Ltd
HKEX:106
|
HK |
|
Anyang Iron and Steel Co Ltd
SSE:600569
|
CN |
|
Zhengzhou Coal Mining Machinery Group Co Ltd
HKEX:564
|
CN |
|
T
|
Taaleri Oyj
OMXH:TAALA
|
FI |
|
Mitsuboshi Co Ltd
TSE:5820
|
JP |
|
W
|
Westwater Resources Inc
AMEX:WWR
|
US |
|
Titan Company Ltd
NSE:TITAN
|
IN |
|
CRH PLC
LSE:CRH
|
IE |
|
nCino Inc
F:6NCA
|
US |
|
Calix Ltd
ASX:CXL
|
AU |
During the last 3 months Immunome Inc insiders bought 544.3k USD , and sold 2.9m USD worth of shares. The stock price has increased by 3% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/imnm/vs/indx/gspc">open performance analysis).
The last transaction was made on
Apr 2, 2026
by
Rosett Max
, who
sold
1.4m USD
worth of
IMNM shares.
During the last 3 months Immunome Inc insiders bought 544.3k USD , and sold 2.9m USD worth of shares. The stock price has increased by 3% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/imnm/vs/indx/gspc">open performance analysis).
The last transaction was made on
Apr 2, 2026
by
Rosett Max
, who
sold
1.4m USD
worth of
IMNM shares.
Immunome Inc
Glance View
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. The company is headquartered in Exton, Pennsylvania and currently employs 39 full-time employees. The company went IPO on 2020-10-02. The firm's primary focus areas are oncology and infectious diseases. Its discovery platform identifies therapeutic antibodies and their targets by leveraging components of the immune system, memory B cells, from patients who have learned to fight off their disease. Its lead discovery programs include IMM-ONC-01 and IMM-BCP-01. IMM-ONC-01, is its lead oncology program, which is focused on IL-38. IMM-BCP-01, is its lead infectious disease discovery program with a focus on SARS-CoV-2, the virus that causes COVID-19. The firm is developing an antibody cocktail product candidate by identifying a combination of anti-viral antibodies produced by B cells from COVID-19 super-responders.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.